| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |